Yu Jeong Choi
Overview
Explore the profile of Yu Jeong Choi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Choi Y, Min Y, Lee S, Choi J, Shin S
Ann Lab Med
. 2023 Dec;
44(4):335-342.
PMID: 38145892
Background: The three best-known rearrangements found in leukemia (, and ) are associated with treatment resistance and poor prognosis. Mouse experiments have shown that rearrangements alone are insufficient for leukemogenesis;...
12.
Lee B, Hong S, Rha S, Heo J, Hur S, Choi H, et al.
Atherosclerosis
. 2023 Nov;
386:117373.
PMID: 37995599
Background And Aims: Whether the effect of a combination strategy rather than increasing doses of one drug to lower low-density lipoprotein cholesterol (LDL-C) levels is consistent across baseline LDL-C levels...
13.
Choi Y, Kim H, Ahn W, Lee S, Han J, Choi J, et al.
BMC Med Genomics
. 2023 Sep;
16(1):215.
PMID: 37697358
Background: Hereditary hemolytic anemia (HHA) refers to a heterogeneous group of genetic disorders that share one common feature: destruction of circulating red blood cells (RBCs). The destruction of RBCs may...
14.
Lee S, Lee Y, Heo J, Hur S, Choi H, Kim K, et al.
J Am Coll Cardiol
. 2023 Apr;
81(14):1339-1349.
PMID: 37019580
Background: The routine use of high-intensity statins should be considered carefully in elderly patients because of their higher risk of intolerance or adverse events. Objectives: We evaluated the impact of...
15.
Choi Y, Kim Y, Junglim K, Jeong S, Shin J, Shin K, et al.
Ann Lab Med
. 2023 Feb;
43(4):398.
PMID: 36843412
No abstract available.
16.
Choi Y, Kim Y, Junglim K, Jeong S, Shin J, Shin K, et al.
Ann Lab Med
. 2022 Oct;
43(2):196-199.
PMID: 36281514
Imipenemase (IMP)-6-producing sequence type (ST) 235 is a dominant clone of carbapenemase-producing (CPPAE) in Korea. As part of the Antimicrobial Resistance Surveillance System in Korea, we found an increase in...
17.
Choi Y, Kang H, Cho C, Rim J, Lee S, Lim J
Ann Lab Med
. 2022 Oct;
43(2):167-173.
PMID: 36281510
Background: Accurate measurement of glycated hemoglobin (HbA1c) is crucial for a diabetes diagnosis and subsequent patient management. The detection method and presence of variant Hb can interfere with HbA1c measurements....
18.
Yoon Y, Park G, Roh J, Her S, Lim S, Kang T, et al.
Cardiol Res Pract
. 2022 Oct;
2022:2914385.
PMID: 36213459
Background: The optimal duration of dual antiplatelet therapy (DAPT) after biodegradable-polymer (BP) everolimus-eluting stent (EES) implantation remains uncertain. Methods: This study analyzed 793 patients who underwent percutaneous coronary intervention (PCI)...
19.
Kim Y, Park I, Kim B, Choi Y, Oh S, Lee K
Ann Lab Med
. 2022 Aug;
43(1):64-72.
PMID: 36045058
Background: Following success of the phase III PROfound trial, the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib was approved by the US Food and Drug Administration in May 2020 for adult...
20.
Choi Y, Roh J, Kim S, Lee K, Park Y
Diagnostics (Basel)
. 2021 Dec;
11(12).
PMID: 34943638
Numerous immunoassays have been developed to measure the levels of chromogranin A (CgA), a useful biomarker for diagnosing and monitoring generally heterogeneous neuroendocrine tumors (NETs). Here, we evaluated the imprecision...